Affiliation:
1. Zhejiang ProvincialPeoplès Hospital, Hangzhou Medical College
2. Sun Yat-sen University Cancer Center
Abstract
Abstract
Background
Breast cancer (BC) patients tend to suffer from distant metastasis, especially bone metastasis.
Methods
All the analysis based on open-accessed data was performed in R software, dependent on multiple algorithms and packages. The RNA levels of specific genes were detected using quantitative Real-time PCR as a method of detecting the RNA levels. In order to assess the ability of BC cells to proliferate, we utilized the CCK8 test, colony formation and the 5-Ethynyl-20-deoxyuridine assay. BC cells were evaluated for invasion and migration by using Transwell assays and wound healing assays.
Results
In our study, we identified the molecules involved in BC bone metastasis based on the data from multiple BC cohorts. Then, we comprehensively investigated the effect pattern and underlying biological role of these molecules. We found that in the identified molecules, the EMP1, ACKR3, ITGA10, MMP13, COL11A1, and THY1 were significantly correlated with patient prognosis and mainly expressed in CAFs. Therefore, we explored the CAFs in BC microenvironment. Results showed that CAFs could activate multiple carcinogenic pathways and most of these pathways play important role in cancer metastasis. Meanwhile, we noticed the interaction between CAFs and malignant, endothelial and M2 macrophage cells. Moreover, we found that CAFs could induce the remodeling of BC microenvironment and promote the malignant behavior of BC cells. Then, we identified MMP13 for further analysis. It was found that MMP13 can enhance the malignant phenotype of BC cells. Meanwhile, biological enrichment and immune infiltration analysis were conducted to present the effect pattern of MMP13 in BC.
Conclusions
Our result can improve the understanding of researchers on the underlying mechanisms of BC bone metastasis.
Publisher
Research Square Platform LLC
Reference49 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer statistics. 2022. CA: a cancer journal for clinicians. 2022;72(1):7–33.
2. Immune Landscape of Breast Cancers;Nagarajan D;Biomedicines,2018
3. Makhoul I, Atiq M, Alwbari A, Kieber-Emmons T. Breast Cancer Immunotherapy: An Update. Breast cancer: basic and clinical research. 2018;12:1178223418774802.
4. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China;Zhu X;Breast Cancer Res Treat,2014
5. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann BD;J Clin Investig,2011